Therapeutic benefits of phosphodiesterase-5 inhibition in chronic heart failure: A meta-analysis

BACKGROUND: Phosphodiesterase-5 inhibitors (PDE5i) have been shown to be beneficial for patients with pulmonary arterial hypertension. However, several studies would have documented a useful effect of PDE5i even for pulmonary hypertension secondary to left-sided chronic heart failure (CHF). METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Vecchis, Renato De, Cesaro, Arturo, Ariano, Carmelina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Akadémiai Kiadó 2017
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5700700/
https://www.ncbi.nlm.nih.gov/pubmed/29201436
http://dx.doi.org/10.1556/1646.9.2017.26

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5700700/
https://www.ncbi.nlm.nih.gov/pubmed/29201436
http://dx.doi.org/10.1556/1646.9.2017.26

Ejemplares similares